Advanced searches left 3/3

Rabies Vaccine - DOAJ

Summarized by Plex Scholar
Last Updated: 16 July 2022

* If you want to update the article please login/register

Antibody response to Raboral VR-G® oral rabies vaccine in captive and free-ranging black-backed jackals (Canis mesomelas)

In northern South Africa's northern areas, the black-backed jackals is the primary mosquito vector responsible for rabies outbreaks. At 4 weeks and ten weeks, nine captive jackals had protective antibody titres at 4 weeks and ten jackals had at 12 weeks and three others had stable antibody titres for up to 48 weeks. This resulted in enhanced antibody titres in 3/11 jackals trapped between 3 and 12 months in north-eastern South Africa, relative to 4/7 jackals trapped after 3u201318 months in central South Africa. In north-eastern and central South Africa, this research shows the potential value of oral rabies vaccination for the prevention of wildlife-associated rabies, but more research is needed to determine the potential effect on rabies control in wild jackals.

Source link: https://doi.org/10.4102/ojvr.v89i1.1975


Effect of a booster-dose of rabies vaccine on the duration of virus neutralizing antibody titers in bovines

In 35 nelore cross-bred bovines of the western region of Su00e3o Paulo province of Su00e3o Paulo state, a study of inactivated rabies vaccine was investigated. After 270 days, 9 sera developed titers 30. 5IU/ml, but only one showed a titer of 0. 51IU/ml, and after 360 days, all animals had titers 0. 5IU/ml. Both groups of animals were given a booster dose 30 days after vaccination was administered, two months after, with titers > 0. 5IU/ml.

Source link: https://doaj.org/article/0ccb6a9133a249b397f94ce4935abfe5


Adverse reactions associated with a Fuenzalida-Palacios rabies vaccine: a quasi-experimental study

In South America, the Fuenzalida-Palacios rabies vaccine has been used for rabies post-exposure prophylaxis. Compared to the occurrence of a list of signs and symptoms, victims of bites or other injuries of dogs or other mammals, as well as others who received or not post-exposure prophylaxis with Fuenzalida-Palacios rabies vaccine were compared. Patients who were given the Fuenzalida-Palacios rabies vaccine and those that did not had similar symptoms had similar symptoms. Fuenzalida-Palacios rabies vaccine is a safe alternative to rabies post-exposure prophylaxis in the case of adverse reactions.

Source link: https://doaj.org/article/d65573e44f3745dc8018a0569d3a060a


Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers.

Since 2013, rabies infections have been recorded among Formosan ferret badgers in Taiwan, and they have been deemed as the main reservoirs for Taiwanese enzootics. This report looked at the safety, efficiency, and immunogenicity of SAG2 vaccine on ferret badgers by direct oral instillation before delivering live vaccines in the field. In Taiwan, SAG2 is the most popular vaccine candidate to shield Formosan ferret badgers against rabies, according to immunization and security results after a single vaccination dose.

Source link: https://doi.org/10.1371/journal.pone.0184831


Rabies vaccine initiation and adherence among animal-bite patients in Haiti, 2015.

BACKGROUND: Around 59,000 people die from rabies around the world each year. Haiti is one of the few remaining countries in the Western Hemisphere with endemic canine rabies. PEP is widely available in countries where PEP is widely available, but differences in healthcare seeking habits and a lack of adheren to established treatment guidelines can all contribute to these deaths. FINDINGS: We discovered 2. 5 times more animal-bite case-patients during the 6 months study period than were expected by the national surveillance agency. At least one rabies vaccine was provided to 110 of the case-patients who requested medical attention, with 110 of the case-patients receiving medical attention. When comparing vaccination status and patient characteristics, we discovered a significant correlation between bite location, severity rank score, geographical location, and healthcare facility type vaccination. Given that the Haitian government provides PEP to the people for free and dog-bite victims are receiving medical attention in a timely manner, reduce rabies deaths is a realistic aim. u2500 lowering rabies deaths is a attainable target.

Source link: https://doi.org/10.1371/journal.pntd.0006955


Using Intradermal Rabies Vaccine to Boost Immunity in People with Low Rabies Antibody Levels

The rabies vaccine was previously given to a group of 12 adults in England who were previously exposed intradermal rabies vaccine, but their rabies antibody titres were reported to be less than 0. 5 IU/mL. Within the limits of a small study, the results point to the fact that adequate levels of rabies antibodies can be achieved by an intradermal injection regimented on at least three occasions with a cumulative rabies vaccine dose of 2. 0 IU.

Source link: https://doi.org/10.4061/2011/601789


Epidemiology of animal bites and other potential rabies exposures and anti-rabies vaccine utilization in a rural area in Southern Ethiopia

During a period of 43 months, the present study explores the epidemiology of alleged rabies exposures and evaluates the use of anti-rabies vaccine in a rural area of Ethiopia. Children under the age of 15 years were more likely to be exposed to dogs than adults. While children were in contact with animals more often than adults, they were in contact with u2019 than adults. Animal bites in rural Ethiopia, mainly among children, persist to be a problem. In order to avoid rabies in this population, efforts to shield children from animal bites must be of utmost importance.

Source link: https://doaj.org/article/44a6d78bec2745daafa9b2143b39dae5


Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIX

Abstract Background: To most effectively reduce and eliminate rabies in humans, mass vaccination of dogs as a vital rabies reservoir is suggested. Dog vaccination rates in many developing countries are still dangerously low due to economic difficulties and a high turnover in dog populations. Cell lines of the muscovy-duck derived AGE1. CR and AGE1. CR. pIX suspension cell lines were tested and optimized in this research. Both cell lines were able to replicate rabies virus in the absence of recombinant IGF, the only complicated component of the chemically defined medium that was used for the two cell lines. According to the NIH protocol, the potency of activated rabies virus harvest was 3. 5 IU/ml. Conclusion This research shows that a rabies vaccine for animal vaccination can be manufactured quickly in the AGE1. CR. pIX suspension cell line in a scalable process in chemically defined medium.

Source link: https://doi.org/10.1186/s12896-022-00747-5


A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein

This paper explores the development of a novel recombinant bovine herpes virus type I expressing rabies virus glycoprotein rather than its gE glycoprotein by CRISPR-Cas9 and homologous recombination techniques. After 20 rounds of in vitro passage, the recombinant virus replicates to high titers in MDBK cells, insertion of the RABV G gene remains stable. In the recombinant virus-infected cells and on the virion surface of BHV-1-u0394gE-G, one single immunization with BHV-1-u0394gB-activated dendritic cells and B cells also produced a protective immune response in mice against severe lethal challenge infection.

Source link: https://doi.org/10.3389/fmicb.2022.931043

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions